Renal Biomarkers Market Overview

Renal biomarkers are crucial for diagnosing and identifying patients at risk of developing kidney diseases by measuring their levels in blood or urine. These biomarkers are typically released during acute or chronic kidney injuries, which involve the rapid or gradual loss of kidney function, leading to serious clinical consequences.

Request for free sample:https://www.datamintelligence.com/download-sample/renal-biomarkers-market

Renal Biomarkers Market Growth Trends

Advancements in genetic technology over the past decade have significantly enhanced our understanding of genetic regulatory pathways related to renal biomarkers. Rapid progress in genomic technologies has made genetic analysis an essential component of clinical practice and research. Additionally, developments in computer technology have made renal biomarker testing widely accessible and feasible, even for small laboratories. These genetic advancements have opened new avenues for studying kidney disease across diverse platforms and populations. Renal biomarkers can now be integrated into genetic-level technological advancements for the detection, diagnosis, and treatment of kidney diseases. Consequently, these innovations have led to the development of more advanced renal biomarkers, driving market growth.

Chronic kidney disease (CKD) is a major risk factor for cardiovascular disease, diabetes, hypertension, glomerulonephritis, and aging. World Kidney Day, a global awareness campaign, estimates that 10% of the global population is affected by CKD. According to the Centers for Disease Control and Prevention (CDC), over 26 million Americans are affected by CKD. If untreated, CKD can progress to end-stage renal disease (ESRD). The National Kidney Foundation estimated that in 2015, about 468,000 ESRD patients in the U.S. were on dialysis.

Get your customized report @https://www.datamintelligence.com/customize/renal-biomarkers-market

Renal Biomarkers Market is segmented
By Assay Platform Type: Chemiluminescent Enzyme Immunoassay (CLIA), Colorimetric Assay, Enzymatic Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Liquid Chromatography-Mass Spectrometry (LS-MS
By Type: Functional Biomarker, Up-Regulated Proteins, Others
By End Users: Diagnostic Labs, Hospitals, Outpatient Clinics, Research Centre’s
By Region: North America, Latin America, Europe, Asia Pacific, Middle East, and Africa

Renal Biomarkers Companies
• Abbott Laboratories
• BioPorto Diagnostics AS
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific Inc.
• Pacific Biomarkers
• BioMérieux
• Beckman Coulter (Danaher Corporation)
• Randox Laboratories Ltd
• Siemens Healthineers
• Alere Inc.

Related Reports
Allergy Diagnostics Market
Fetal Monitors Market
Companion Diagnostics Market

Contact Us:
Company Name: DataM Intelligence
Email: [email protected]
Contact Person: Sai. K
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence:
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights, and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across.